Back to Atlas
BSemi-durableNootropic/stimulant caution
CMP-0231
Research
PRL-8-53
Nootropic
Verbal-memory enhancement positioning
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Small molecule
- Primary mechanism
- Memory-enhancement mechanism unclear
- Primary market use
- Cognition
Pharmacology
- Molecular weight (Da)
- ~299.8 (HCl)
- Oral bioavailability
- Unknown
- Half-life
- ~2–12 h small-molecule class estimate
- Route tags
- Oral
- Evidence level
- Limited human
- Clinical status
- Research
- Value-for-money score
- 5 / 10
Reported protocol signal
No popular protocol verified yet; keep as reference compound until protocol signal is added.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Classic experimental nootropic